Weber E, Moore M A, Bannasch P
Institute for Experimental Pathology, German Cancer Research Center, Heidelberg, FRG.
Carcinogenesis. 1988 Jul;9(7):1191-5. doi: 10.1093/carcin/9.7.1191.
Dietary administration of 0.25% dehydroepiandrosterone (DHEA) during and subsequent to 7 weeks treatment with N-nitrosomorpholine (NNM) resulted in significantly reduced development of adrenal cortical lesions and hemangiosarcomas in the liver. In addition, distinct phenotypic modulation of hepatocellular tumours was observed after combined hormone and carcinogen treatment. Thus the neoplasms were characterized by a higher degree of differentiation, lower mitotic rate and reduced potential for metastasis as compared to tumours observed after NNM alone. The data clearly indicate that DHEA exerts an inhibitory effect on both adrenal and hepatocarcinogenesis similar to that earlier reported for neoplasia in lung, thyroid, colon and skin.
在使用N-亚硝基吗啉(NNM)治疗7周期间及之后,给予0.25%脱氢表雄酮(DHEA)进行饮食管理,可显著减少肾上腺皮质病变和肝脏血管肉瘤的发生。此外,在联合激素和致癌物治疗后,观察到肝细胞肿瘤有明显的表型调节。因此,与单独使用NNM后观察到的肿瘤相比,这些肿瘤的特征是分化程度更高、有丝分裂率更低且转移潜能降低。数据清楚地表明,DHEA对肾上腺和肝癌发生均有抑制作用,这与之前报道的其对肺、甲状腺、结肠和皮肤肿瘤形成的抑制作用相似。